SCHEMBL6869750

SCHEMBL6869750

C#CC(c1ccccc1)c1ccccc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACP3 P15309 1/20 0.44
▸ ESR1 P03372 1/20 0.42
▸ OPRM1 P35372 4/20 0.39
▸ CYP2D6 P10635 2/20 0.39
▸ SLC22A2 O15244 1/20 0.39
▸ SLC22A1 O15245 1/20 0.39
▸ GRIN2D O15399 1/20 0.39
▸ GRIN3B O60391 1/20 0.39
▸ CHRM2 P08172 1/20 0.39
▸ CHRM4 P08173 1/20 0.39
▸ CHRM5 P08912 1/20 0.39
▸ ADRA2A P08913 1/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ ADRA2B P18089 1/20 0.39
▸ CHRM3 P20309 1/20 0.39
▸ DRD1 P21728 1/20 0.39
▸ SLC6A2 P23975 1/20 0.39
▸ HRH2 P25021 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ HTR2C P28335 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11408107 0.85 IDO1 (0.36) ACP3CYP2D6HTR2ATSHR
SCHEMBL29031377 0.80 ACP3 (0.44) ACP3ESR1OPRM1CYP2D6SLC22A2
SCHEMBL2106150 0.78 TSHR (0.41) CYP2D6HTR2AHRH1GAANPSR1
SCHEMBL3795426 0.73 ACHE (0.42) CYP2C19CYP3A4CYP2C9GAALMNA
SCHEMBL6069562 0.72 CHRNB2 (0.41) ACP3CYP3A4TSHRALDH1A1
SCHEMBL2422170 0.72 ACP3 (0.52) ACP3ESR1OPRM1CYP2D6SLC22A2
SCHEMBL5270216 0.72 ACP3 (0.52) ACP3ESR1OPRM1CYP2D6SLC22A2
SCHEMBL10836507 0.71 ESR1 (0.45) ACP3ESR1OPRM1CYP2D6SLC6A2
SCHEMBL11603883 0.70 ACP3 (0.55) ACP3ESR1CYP2D6CHRM2ADRA2A
SCHEMBL710709 0.70 ACP3 (0.50) ACP3ESR1OPRM1CYP2D6SLC22A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1438309-A1 QUINUCLIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS M2 AND/OR M3 MUSCARINIC RECEPTOR INHIBITORS UCB, S.A. (BE) 2004-07-21 — — EP disclosed
WO-2003033495-A1 QUINUCLIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS M2 AND/OR M3 MUSCARINIC RECEPTOR INHIBITORS UCB, S.A. (BE) 2003-04-24 — — WO disclosed
Send feedback